Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023;32(1):98.
doi: 10.1159/000528530. Epub 2023 Jan 10.

Reply to: "Qualitative Evaluation of α-Synuclein: A Critical Step in Unravelling the Complexities of Autism Spectrum Disorder"

Sarah H Al-Mazidi  1 , Laila Y Al-Ayadhi  2   3
Affiliations
Comment

Reply to: "Qualitative Evaluation of α-Synuclein: A Critical Step in Unravelling the Complexities of Autism Spectrum Disorder"

Sarah H Al-Mazidi et al. Med Princ Pract. 2023.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Al-Mazidi S, Al-Ayadhi LY. Plasma levels of alpha and gamma synucleins in autism spectrum disorder an indicator of severity. Med Princ Pract. 2021;30((2)):160–167. https://www.karger.com/DOI/10.1159/000513935 . - DOI - PMC - PubMed
    1. Preethy S, Raghavan K, Ikewaki N, Abraham SJK. Qualitative evaluation of α-synuclein a critical step in unravelling the complexities of autism spectrum disorder. Med Princ Pract. 2022 doi: 10.1159/000527728. - PMC - PubMed
    1. El-Ansary AM, Alhakbany M, Aldbass A, Qasem H, Al-Mazidi S, Bhat RS. Alpha-Synuclein cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders use of combined ROC curves to increase their diagnostic values. Lipids Health Dis. 2021;20((1)):155–167. - PMC - PubMed
    1. Raghavan K, Dedeepiya VD, Ikewaki N, Sonoda T, Iwasaki M, Preethy S, et al. Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised parallel-group pilot clinical study. BMJ Neurol Open. 2022;4((1)):e000203. - PMC - PubMed
    1. Abou-Donia MB, Suliman HB, Siniscalco D, Antonucci N, ElKafrawy P. De novo blood biomarkers in autism autoantibodies against neuronal and glial proteins. Behav Sci. 2019;9((5)):47–64. - PMC - PubMed

Substances